Información:
Error:
ID
15781
Descripción
Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Suspected Metastatic Renal Cell Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01689662
Link
https://clinicaltrials.gov/show/NCT01689662
Palabras clave
Versiones (1)
- 13/6/16 13/6/16 -
Subido en
13 de junio de 2016
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Metastatic Renal Cell Carcinoma NCT01689662
Eligibility Metastatic Renal Cell Carcinoma NCT01689662
- StudyEvent: Eligibility
Similar models
Eligibility Metastatic Renal Cell Carcinoma NCT01689662
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
age
Item
1. subject must be 18 years of age or older.
boolean
C0001779 (UMLS CUI [1])
metastatic renal cell carcinoma
Item
2. subject must have known or strongly suspected metastatic renal cell carcinoma with at least one target lesion as identified by ultrasonography, mri, or ct.
boolean
C0278678 (UMLS CUI [1])
kidney function
Item
3. subject must have good kidney function.
boolean
C0232804 (UMLS CUI [1])
written informed
Item
4. subject must provide written informed consent prior to enrollment.
boolean
C0021430 (UMLS CUI [1])
pregnancy or breast-feeding
Item
1. subject is pregnant or breastfeeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
participating in another study
Item
2. subject is simultaneously participating in another investigational drug study, excluding the follow-up phase.
boolean
C2348568 (UMLS CUI [1])
investigational agent
Item
3. subject has received an investigational agent within 7 days prior to enrollment.
boolean
C1875319 (UMLS CUI [1])
radionuclide imaging
Item
4. subject is unable to tolerate conditions for radionuclide imaging.
boolean
C0034606 (UMLS CUI [1])
technetium tc 99m ec20
Item
5. subject has been administered another radiopharmaceutical that would interfere with the assessment of technetium tc 99m ec20.
boolean
C0182638 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C1883272 (UMLS CUI [1,3])
C0521102 (UMLS CUI [1,2])
C1883272 (UMLS CUI [1,3])